ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of Medical and In Vitro Diagnostic Devices in the New EU Public Consultation

Clear clinical standards and structured expertise must anchor the EU’s approach to cancer diagnostics under the Health Technology Assessment (HTA) framework

Source